Effects of glucagon-like peptide-1-(7-36)-amide on pancreatic islet and intestinal blood perfusion in Wistar rats and diabetic GK rats

Clinical Science

Volumn 112, Issue 5-6, 2007, Pages 345-351

  Svensson, Annika M ^a,c   Östenson, Claes Göran ^b   Efendic, Suad ^b   Jansson, Leif ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

GK rat; Glucagon like peptide 1 (7 36) amide (GLP 1); Islet blood flow; Type 2 diabetes (non insulin dependent diabetes)

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCOSE; INSULIN; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON BLOOD FLOW; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HYPERGLYCEMIA; INTESTINE BLOOD FLOW; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; COLON; DIABETES MELLITUS, EXPERIMENTAL; DUODENUM; FEMALE; GLUCAGON-LIKE PEPTIDE 1; INSULIN; INTESTINES; ISLETS OF LANGERHANS; MICROSPHERES; PANCREAS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW;

EID: 33847791077     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20060272     Document Type: Article

References (48)

1. Porte, Jr, D. (1991) β-Cells in type II diabetes mellitus. Diabetes 40, 166-180
2. Efendic, S., Khan, A. and Östenson, C. G. (1994) Insulin release in type 2 diabetes mellitus. Diabetes Metab. 20, 81-86
3. Holst, J. J. (1999) Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential. Curr. Med. Chem. 6, 1005-1017
4. Holst, J. J. (2006) Glucagon-like peptide-1: from extract to agent. Diabetologia 49, 253-260
5. Dachicourt, N., Serradas, P., Bailbe, D., Kergoat, M., Doare, L. and Portha, B. (1997) Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent β-cells in diabetic rats: in vivo and in vitro studies. J. Endocrinol. 155, 369-376
6. Holst, J. J., Örskov, C., Nielsen, O. V. and Schwartz, T. W. (1987) Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett. 211, 169-174
7. Mojsov, S., Weir, G. C. and Habener, J. F. (1987) Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79, 616-619
8. Örskov, C. (1992) Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 35, 701-711
9. Göke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J. and Göke, B. (1993) Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells. J. Biol. Chem. 268, 19650-19655
10. Creutzfeldt, W. and Ebert, R. (1985) New developments in the incretin concept. Diabetologia 28, 565-573
11. Gutniak, M., Örskov, C., Holst, J. J., Ahrén, B. and Efendic, S. (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 326, 1316-1322
12. Edwards, C. M., Todd, J. F., Mahmoudi, M. et al. (1999) Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes 48, 86-93
13. Ahrén, B., Larsson, H. and Holst, J. J. (1997) Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82, 473-478
14. Nauck, M. A. (1999) Is glucagon-like peptide 1 an incretin hormone? Diabetologia 42, 373-379
15. Ahrén, B. (2004) GLP-1 and extra-islet effects. Horm. Metab. Res. 36, 842-845
16. Gutzwiller, J. P., Göke, B., Drewe, J. et al. (1999) Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 44, 81-86
17. Thorens, B. (1992) Expression cloning of the pancreatic β-cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. U.S.A. 89, 8641-8645
18. Moens, K., Heimberg, H., Flamez, D. et al. (1996) Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45, 257-261
19. Montrose-Rafizadeh, C., Avdonin, P., Garant, M. J. et al. (1999) Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells. Endocrinology 140, 1132-1140
20. 2+ mobilization. FEBS Lett. 425, 277-280
21. Gromada, J., Holst, J. J. and Rorsman, P. (1998) Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflügers Arch. 435, 583-594
22. Fernandez, J. and Valdeolmillos, M. (1999) Glucose-dependent stimulatory effect of glucagon-like peptide 1(7-36) amide on the electrical activity of pancreatic β-cells recorded in vivo. Diabetes 48, 754-757
23. Heller, R. S., Kieffer, T. J. and Habener, J. F. (1997) Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing α-cells of the rat endocrine pancreas. Diabetes 46, 785-791
24. Iltz, J. L., Baker, D. E., Setter, S. M. and Campbell, K. R. (2006) Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus. Clin. Ther. 28, 652-665
25. Ahrén, B. and Schmitz, O. (2004) GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes. Horm. Metab. Res. 36, 867-876
26. 1-hybrids of the non-insulin-dependent diabetic GK-Wistar rat. Eur. J. Endocrinol. 130, 612-616
27. G-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats. Endocrinology 135, 849-853
28. Carlsson, P. O., Andersson, A. and Jansson, L. (1998) Influence of age, hyperglycemia, leptin, and NPY on islet blood flow in obese-hyperglycemic mice. Am. J. Physiol. 275, E594-E601
29. Jansson, L. (1994) The regulation of pancreatic islet blood flow. Diabetes Metab. Rev. 10, 407-416
30. Kimura, K., Toyota, T., Kakizaki, M., Kudo, M., Takebe, K. and Goto, Y. (1982) Impaired insulin secretion in the spontaneous diabetes rats. Tohoku J. Exp. Med. 137, 453-459
31. Goto, Y., Suzuki, K., Ono, T., Sasaki, M. and Toyota, T. (1988) Development of diabetes in the non-obese NIDDM rat (GK rat). Adv. Exp. Med. Biol. 246, 29-31
32. Jansson, L. and Hellerström, C. (1983) Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia 25, 45-50
33. Jansson, L. and Hellerström, C. (1981) A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using non-radioactive microspheres. Acta Physiol. Scand. 113, 371-374
34. Atef, N., Portha, B. and Penicaud, L. (1994) Changes in islet blood flow in rats with NIDDM. Diabetologia 37, 677-680
35. Carlsson, P. O., Jansson, L., Östenson, C. G. and Källskog, Ö. (1997) Islet capillary blood pressure increase mediated by hyperglycemia in NIDDM GK rats. Diabetes 46, 947-952
36. Brunicardi, F. C., Stagner, J., Bonner-Weir, S. et al. (1996) Microcirculation of the islets of Langerhans. Diabetes 45, 385-392
37. Richter, G., Feddersen, O., Wagner, U., Barth, P., Goke, R. and Goke, B. (1993) GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. Am. J. Physiol. 265, L374-L381
38. Wahren, J. and Eriksson, L. S. (1986) The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis. Scand. J. Gastroenterol. Suppl. 119, 103-108
39. Samnegard, H., Thulin, L., Andreen, M., Tyden, G., Hallberg, D. and Efendic, S. (1979) Circulatory effects of somatostatin in anaesthetized dogs. Acta Chir. Scand. 145, 209-212
40. Jenkins, S. A., Baxter, J. N., Corbett, W. A. and Shields, R. (1985) Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man. Br. J. Surg. 72, 1009-1012
41. Carlsson, P. O. and Jansson, L. (1994) The long-acting somatostatin analogue octreotide decreases pancreatic islet blood flow in rats. Pancreas 9, 361-364
42. Fehmann, H. C. and Habener, J. F. (1991) Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line. FEBS Lett. 279, 335-340
43. Wojdemann, M., Wettergren, A., Sternby, B. et al. (1998) Inhibition of human gastric lipase secretion by glucagon-like peptide-1. Dig. Dis. Sci. 43, 799-805
44. Giralt, M. and Vergara, P. (1999) Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat. Dig. Dis. Sci. 44, 322-329
45. Svensson, A. M., Efendic, S., Östenson, C. G. and Jansson, L. (1997) Gastric inhibitory polypeptide and splanchnic blood perfusion: augmentation of the islet blood flow increase in hyperglycemic rats. Peptides 18, 1055-1059
46. Svensson, A. M., Östenson, C. G. and Jansson, L. (2000) Age-induced changes in pancreatic islet blood flow: evidence for an impaired regulation in diabetic GK rats. Am. J. Physiol. Endocrinol. Metab. 279, E1139-E1144
47. Zatz, R. and Brenner, B. M. (1986) Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am. J. Med. 80, 443-453
48. Parving, H. H., Viberti, G. C., Keen, H., Christiansen, J. S. and Lassen, N. A. (1983) Hemodynamic factors in the genesis of diabetic microangiopathy. Metab., Clin. Exp. 32, 943-949